Literature DB >> 9884398

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.

M D Cheitlin, A M Hutter, R G Brindis, P Ganz, S Kaul, R O Russell, R M Zusman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9884398     DOI： 10.1161/01.cir.99.1.168

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  45 in total

Review 1.  Pulse wave analysis.

Authors:  M F O'Rourke; A Pauca; X J Jiang
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

Review 2.  Treatments for diabetic neuropathy.

Authors:  A J Boulton
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

3.  Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports.

Authors:  Ikuko Hayakawa; Fumiaki Shirasaki; Takashi Hirano; Naoto Oishi; Minoru Hasegawa; Shinichi Sato; Kazuhiko Takehara
Journal:  Rheumatol Int       Date:  2005-05-25       Impact factor: 2.631

Review 4.  [Medicinal vasoactive therapy of microcirculation disorders in rheumatoid arthritis].

Authors:  G Riemekasten; H Schulze-Koops
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

Review 5.  Sexual activity and ischemic heart disease.

Authors:  Richard A Lange; Glenn N Levine
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

Review 6.  Safety of sildenafil in infants*.

Authors:  Samira Samiee-Zafarghandy; P Brian Smith; Johannes N van den Anker
Journal:  Pediatr Crit Care Med       Date:  2014-05       Impact factor: 3.624

Review 7.  Etiology and treatment of erectile failure in diabetes mellitus.

Authors:  Donald Richardson; Aaron Vinik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 8.  Erectile dysfunction and diabetes.

Authors:  Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  Sildenafil citrate does not affect QT intervals and QT dispersion: an important observation for drug safety.

Authors:  Mete Alpaslan; Ersel Onrat; Murat Samli; Cetin Dincel
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

10.  Sildenafil citrate does not alter ventricular repolarization properties: novel evidence from dynamic QT analysis.

Authors:  Dayimi Kaya; Cem Guler; Ali Metin Esen; Irfan Barutcu; Cetin Dincel
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.